Drug delivery using natural biological carriers, especially erythrocytes, is a rapidly
developing field. Such erythrocytes can act as carriers that prolong the drug's action due to …

Iron oxide contrast agents have been combined with magnetic resonance imaging for cell
tracking. In this review, we discuss coating properties and provide an overview of ex vivo …

Here, kartogenin (KGN), an emerging stable nonprotein compound with the ability to
promote differentiation of bone marrow-derived mesenchymal stem cells (BMSCs) into …

Superparamagnetic iron oxide nanoparticles (SPION) are available since many years and
some of them are already approved for human use. New applications are currently emerging …

The regeneration of cartilage is a challenging problem for lack of innate abilities to mount a
sufficient healing response. Kartogenin (KGN), an emerging chondroinductive non-protein …

Recently optimized technologies that permit the reversible opening of nanopores across the
red blood cell membrane, give the extraordinary opportunity for reengineering human …

Pharmacokinetics, biodistribution, and biological activity are key parameters that determine
the success or failure of therapeutics. Many developments intended to improve their in vivo …

Aim: Magnetic particle imaging (MPI) is highly promising for biomedical applications, but
optimal tracers for MPI, namely superparamagnetic iron oxide-based contrast agents, are …

New biomedical strategies are being developed to improve disease detection, therapeutic
monitoring, and treatment efficacy in several contexts for example in anti-angiogenic …

Superparamagnetic iron oxide (SPIO) and ultra small superparamagnetic iron oxide
(USPIO) nanoparticles have been developed as magnetic resonance imaging (MRI) contrast …